Advertisement

Topics

ALK-Abelló: ALK's HDM SLIT-tablet, ACARIZAX®, approved in Canada

15:16 EDT 4 May 2017 | FinanzNachrichten

Copenhagen, 2017-05-04 21:07 CEST (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that its house dust mite (HDM) sublingual allergy immunotherapy (SLIT) tablet, ACARI...

Original Article: ALK-Abelló: ALK's HDM SLIT-tablet, ACARIZAX®, approved in Canada

NEXT ARTICLE

More From BioPortfolio on "ALK-Abelló: ALK's HDM SLIT-tablet, ACARIZAX®, approved in Canada"

Quick Search
Advertisement
 

Relevant Topics

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...